Frederick, MD · Health Care · Form D filed Aug 4, 2026
Theradaptive, Inc. raised $36.2M
Theradaptive, Inc. is a biotechnology company based in Frederick, Maryland. In a Form D filed with the SEC on August 4, 2026, it reported raising $36,156,177 from 65 investors as part of an offering of up to $77,925,166. The first sale in the offering took place on July 21, 2026.
Theradaptive aims to redefine the regenerative medicine field by delivering therapeutics to any location in the body with precision.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
- Still raising. $41.8M of the $77.9M offering was still unsold at filing.
$36.2M raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 4, 2026 | $36.2M | $77.9M | 65 |
Lead score
50 out of 100
first raise ever still raising budget to spend website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- theradaptive.com
- Amount raised
- $36,156,177
- Offering size
- $77,925,166
- Investors so far
- 65
- First sale
- July 21, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Frederick, Maryland
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $36,156,177 | $77,925,166 | 65 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 3, 2026 · Health Care funding in Maryland · August 2026 funding report
Similar raises
Inventwood Inc.
Frederick, MD · filed Oct 8
Introducing the reinvention of wood: Superwood. Stronger than steel. The soul of wood.
3rd Form D since 2025Still raising
Kaigene, Inc.
Rockville, MD · filed Oct 142nd Form D since 2022Still raising
ColoWatch, Inc.
Gaithersburg, MD · filed Oct 8
Virtual colonoscopy screening with no sedation, standardized protocols, secure cloud delivery, advanced 3D visualization, and expert radiologist interpretation.
First Form DStill raising
Templar Nova, Inc.
Rockville, MD · filed Oct 7First Form D
Monocacy Therapeutics Inc.
Monrovia, MD · filed Oct 75th Form D since 2026
Seraxis Holdings, Inc.
Germantown, MD · filed Sep 24
Seraxis is a private biotechnology company that has developed a novel cell and immune-evasion technology with the goal to reverse Type 1 Diabetes.
2nd Form D since 2021
Aromha, Inc.
Potomac, MD · filed Sep 243rd Form D since 2025
Uvantis Therapeutics, Inc.
Columbia, MD · filed Sep 23First Form DStill raising